Therapeutic Asset Ratings

184 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tislelizumab Triple Negative Breast Cancer	National University Hospital, Singapore	P2	B (56)
Fludarabine Triple Negative Breast Cancer	Canadian Cancer Trials Group	P2	CCC (54)
Spartalizumab Triple Negative Breast Cancer	SOLTI Breast Cancer Research Group	P2	CCC (54)
ADAGLOXAD SIMOLENIN Triple Negative Breast Cancer	OBI Pharma, Inc	P3	CCC (52)
Eribulin Mesilate Triple Negative Breast Cancer	Jiangsu Alphamab Biopharmaceuticals Co., Ltd	P3	CCC (52)
fda018-adc Triple Negative Breast Cancer	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.	P3	CCC (52)
Jskn016 Triple Negative Breast Cancer	Jiangsu Alphamab Biopharmaceuticals Co., Ltd	P3	CCC (52)
MOXIFLOXACIN Triple Negative Breast Cancer	Sun Yat-Sen University Cancer Center	P3	CCC (52)
Nanosomal Docetaxel Lipid Suspension Triple Negative Breast Cancer	Jina Pharmaceuticals Inc.	P3	CCC (52)
Saponin-Based Immunoadjuvant Obi-821 Triple Negative Breast Cancer	OBI Pharma, Inc	P3	CCC (52)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY- Triple Negative Breast Cancer	Fudan University	P2	CCC (52)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Triple Negative Breast Cancer	OncoNano Medicine, Inc.	P2	CCC (52)
LEUPROLIDE Triple Negative Breast Cancer	National Taiwan University Hospital	P2	CCC (52)
Trastuzumab Emtansine Triple Negative Breast Cancer	National Cancer Institute (NCI)	P2	CCC (52)
Zoladex Triple Negative Breast Cancer	National Taiwan University Hospital	P2	CCC (52)
Girentuximab Triple Negative Breast Cancer	Institut Cancerologie de l'Ouest	P2	CCC (51)
Immunoglobulin G1 [300-alanine], anti-(human CD73 antigen) (human-Mus musculus monoclonal TJ004309 ?1-chain), disulfide with human-Mus musculus monoclonal TJ004309 ?-chain, dimer Triple Negative Breast Cancer	I-Mab Biopharma US Limited	P2	CCC (51)
Loperamide Triple Negative Breast Cancer	MedSIR	P2	CCC (51)
Fruquintinib Triple Negative Breast Cancer	Immunitas Therapeutics	P1/2	CCC (49)
Amiloride Triple Negative Breast Cancer	Laura Huppert, MD, BA	P2	CCC (48)
Bcd-236 Triple Negative Breast Cancer	Biocad	P2	CCC (48)
bdb001 Triple Negative Breast Cancer	Institut Bergonié	P2	CCC (48)
bi 907828 Triple Negative Breast Cancer	Institut Bergonié	P2	CCC (48)
bnt327 Triple Negative Breast Cancer	BioNTech SE	P2	CCC (48)
DESFERRIOXAMINE B Triple Negative Breast Cancer	Sun Yat-sen University	P2	CCC (48)

Showing 51 to 75 of 184 assets

PreviousPage 3 of 8Next